Clostridium Management in Long-Term Care
description
Transcript of Clostridium Management in Long-Term Care
![Page 1: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/1.jpg)
Clostridium Management in Long-Term Care
Spring 2011 Joint Provider/Surveyor Training
Teri Lee Dyke, RN, MSN, CIC
![Page 2: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/2.jpg)
Clostridium difficile Infection (C. diff, CDI, C. difficile & CDAD)
![Page 3: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/3.jpg)
Two Case Reports *[Case 1]
*MMWR 2005;54:1201-5Severe CDAD in populations previously at low risk- four states, 2005
•Case 1
![Page 4: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/4.jpg)
Two Case Reports *[Case 2]
*MMWR 2005;54:1201-5Severe CDAD in populations previously at low risk- four states, 2005
•Case 1
![Page 5: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/5.jpg)
Why C. difficile is interesting
• It is a bacterial infection in which antibiotics cause (or at least contribute to) the disease
• It is one of the only anaerobic organisms that can be a nosocomial pathogen
• Its mechanism of pathogenesis is almost completely toxin production; it does not invade the tissues
• It is the only nosocomial pathogen that forms endospores that are nearly impossible to kill
• The most effective treatment for the disease may be to expose the patient to more bacteria
![Page 6: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/6.jpg)
Outline
• Clostridium Difficile the disease
• Epidemiology• Infection
Prevention/Mitigation• Strategies for
Management in LTC• Resources
![Page 7: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/7.jpg)
C. Difficile the disease
![Page 8: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/8.jpg)
Microbiology
• Description– Gram positive spore-
forming anaerobic bacteria
• Natural habitat– GI tract of mammals
• Identification– Not normally cultured
from stool; difficult to grow
![Page 9: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/9.jpg)
Clostridium difficile
• Anaerobic spore-forming bacillus • Clostridium difficile-associated disease or diarrhea
(CDAD) • Pseudomembranous colitis, toxic megacolon, sepsis,
and death• Fecal-oral transmission through contaminated
environment and hands of healthcare personnel• Antimicrobial exposure is major risk factor for
disease - Acquisition and growth of C. difficile- Suppression of normal flora of the colon
• Clindamycin, penicillins, and cephalosporins Pseudo-membranous
colitis
Healthy colon
![Page 10: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/10.jpg)
Sunenshine et al. Cleve Clin J Med. 2006;73:187-97.
Background: Pathogenesis of CDI
4. Toxin A & B Productionleads to colon damage +/- pseudomembrane
1. Ingestionof spores transmitted
from other patients via the hands of healthcare personnel and environment
2. Germination intogrowing (vegetative)
form
3. Altered lower intestine flora (due to antimicrobial use) allows
proliferation of C. difficile in colon
![Page 11: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/11.jpg)
Background: Epidemiology
Risk Factors
• Antimicrobial exposure
• Acquisition of C. difficile
• Advanced age
• Underlying illness
• Immunosuppression
• Tube feeds
• ? Gastric acid suppression
Main modifiable risk factors
![Page 12: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/12.jpg)
Modes of Transmission
• Fecal-oral– Food– Fomite (contaminated object)
• Person-to-person– Taking care of an ill individual– Fomite (contaminated object)
• Inpatient healthcare setting• Previous antibiotic exposure
![Page 13: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/13.jpg)
Symptoms of CDAD
• Watery diarrhea
• Loss of appetite
• Fever
• Nausea
• Abdominal pain and cramping
![Page 14: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/14.jpg)
Colonization vs. Infection
• Colonization– No clinical symptoms– More common than
disease presence– Patient will test
positive for Clostridium difficile and/or its toxin
• Infection– Watery diarrhea– Abdominal pain– Fever– Nausea/Vomiting– Patient tests positive
for Clostridium difficile and/or its toxin
![Page 15: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/15.jpg)
Laboratory Testing
• Stool culture– Most sensitive ( ↑ false-positives)
– Labor intensive
– Results in 48-96 hours
• Antigen detection– Rapid tests ( < 1 hour)
– Antigen detection by latex agglutination or immunochromatographicassays
– Must be combined with toxin testing to verify diagnosis
![Page 16: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/16.jpg)
Laboratory Testing continued..• Toxin testing*
– Enzyme immunoassay detects toxin A, toxin B or both
• Same-day test results
• Less sensitive than tissue culture cytotoxicity assay
– Tissue culture cytotoxicity assay • detect toxin B only
• Requires technical expertise
• Costly
• 24-28 hours results
• Provides specific and sensitive results for c. difficile
* Toxin is very unstable and degrades at room temperature such that toxin may be undetectable within 2 hours. False-negative test results may result from not conducting
immediate testing or not properly refrigerating specimen
![Page 17: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/17.jpg)
Detection of C. difficile in stool
• Culture; too difficult; the organism is fastidious, takes too long
• Cell-associated antigen test; fast, but doesn’t distinguish between toxin-producers and harmless strains
![Page 18: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/18.jpg)
Detection of C. difficile in stool
• Toxin antigen tests; fast, but less sensitive, can get toxin A or A+B tests *
• PCR; not commercially available, not a toxin test
• Cytotoxicity test; the most sensitive, specific and cost-effective
• One specimen is enough, don’t need 3
•Toxin is very unstable and degrades at room temperature such that toxin may be undetectable within 2 hours. False-negative test results may result from not conducting immediate testing or not properly refrigerating specimen
![Page 19: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/19.jpg)
New strain C. difficile• Standard laboratory tests will not distinguish the
new from conventional strains, although all new strains to date were positive for Toxins A and B
• Distinguished by clinical presentation• Can do PCR for the binary toxin and/or for the
deletion in the repressor gene– Most are also fluoroquinolone-resistant, but that is
not specific for this strain
• Strains can be typed by pulse-field gel electrophoresis, and the new strain shows up as a single clone
![Page 20: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/20.jpg)
CDAD Treatment• Discontinue the offending antibiotic
– 23% of the patients disease will resolve within 2-3 days• Standard initial treatment of toxin-positive patients
– Metronidazole 500 mg three times per day for 10-14 days– No resistance, MIC is 0.25-1, stool level is 10– Clinical response of about 95%, relapse of 5-15%
• Alternative– Vancomycin 125 mg four times per day (relapse 15-30%)– Bacitracin 25,000 units four times per day– Cholestyramine 4 grams three times per day for 10 days
• For relapse– Repeat metronidazole plus rifampin 300 mg twice per day for 10 days– If that fails, go to an alternative
• Replace fluid and electrolytes• Avoid anti-peristaltic agents (lomotil, opiates)• Relapse rate 5-15%
![Page 21: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/21.jpg)
American College of Gastroenterology and SHEA Guidelines
• Discontinue the offending antibiotic or change it • Replace fluids and electrolytes• Avoid antiperistaltic agents• If those fail, try one course of metronidazole (Flagyl)• Do not treat asymptomatic patients• Retreat relapses once with the same regimen• Avoid vancomycin if possible
![Page 22: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/22.jpg)
Epidemiology
![Page 23: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/23.jpg)
Background: Impact
• Hospital-acquired, hospital-onset: 165,000 cases, $1.3 billion in excess costs, and 9,000 deaths annually
• Hospital-acquired, post-discharge (up to 4 weeks): 50,000 cases, $0.3 billion in excess costs, and 3,000 deaths annually
• Nursing home-onset: 263,000 cases, $2.2 billion in excess costs, and 16,500 deaths annually
Campbell et al. Infect Control Hosp Epidemiol. 2009:30:523-33. Dubberke et al. Emerg Infect Dis. 2008;14:1031-8.
Dubberke et al. Clin Infect Dis. 2008;46:497-504. Elixhauser et al. HCUP Statistical Brief #50. 2008.
![Page 24: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/24.jpg)
Heron et al. Natl Vital Stat Rep 2009;57(14). Available at http://www.cdc.gov/nchs/data/nvsr/nvsr57/nvsr57_14.pdf
Background: ImpactAge-Adjusted Death Rate* for
Enterocolitis Due to C. difficile, 1999–2006
*Per 100,000 US standard population
0
0.5
1.0
1.5
2.0
2.5
1999 2003
Rat
e
2000 20042001 20052002 2006Year
MaleFemaleWhiteBlackEntire US population
![Page 25: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/25.jpg)
Challenges • Emergence of a new epidemic strain
– Toxinotype III or “BI” by REA• Distinct from “J” strain of 1989-19921
– Binary toxin as a possible virulence factor• In addition to toxins A and B containing
– 18 bp deletion in tcdC gene• Could lead to increased toxin production (18-fold for
toxin A, 23-fold for toxin B) observed by Warny et al.2
– Increased resistance to fluoroquinolones• Appears responsible for increase in cases• May be responsible for increase in disease severity
1. Johnson S, et al. N Engl J Med. 1999;341:1645-1651.2. Warny M, et al. Lancet. 2005;366:1079-1084.
![Page 26: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/26.jpg)
CDAD Surveillance Data
• Not reportable
• NNIS data up to 1990s
• Started in Northeast, now spread to Midwest and South
![Page 27: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/27.jpg)
From Archibald LK, et al. J Infect Dis. 2004;189:1585–158.
Annual CDAD Rates, Hospitals with >500 Beds, Intensive Care Unit Surveillance Component, NNIS
![Page 28: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/28.jpg)
From McDonald LC, et al. Emerg Infect Dis. 2006;12(3):409-15
National Estimates of US Short-Stay Hospital Discharges with C. difficile as First-Listed
or Any Diagnosis
![Page 29: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/29.jpg)
From McDonald LC, et al. Emerg Infect Dis. 2006;12(3):409-15
Rates of US Short-Stay Hospital Discharges with C. difficile Listed as Any Diagnosis by Region
![Page 30: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/30.jpg)
Acute Care Hospitals with CDAD Outbreaks* Between 2001-2004
*Detected by increases in the number of positive routine clinical laboratory tests for C. difficile.
Data from McDonald LC, et al. N Engl J Med. 2005;353:2433-2441.
2
12
1
1
1
![Page 31: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/31.jpg)
States with the Epidemic Strain of C. difficile Confirmed by CDC and Hines VA labs (N=27),
Updated 4/3/2007
DC
PRAK
HI
![Page 32: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/32.jpg)
Michigan Data
• Death certificates with C. difficile– Underlying cause– Any mention
![Page 33: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/33.jpg)
Death Certificates in Michigan Clostridium Difficile
1999-2005
0
50
100
150
200
250
300
1999 2000 2001 2002 2003 2004 2005
underlying cause of death any mention of C. difficileany mention of C. difficile
![Page 34: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/34.jpg)
Michigan
Deaths with Enterocolitis caused by C. difficile listed as Underlying Cause
020406080
100120140160180
<40 40-49 50-59 60-69 70-79 80-89 90andup
Total
Age
No
. o
f C
as
es
1999
2000
2001
2002
2003
2004
2005
Source: 2005 death file, data records and health data development section MDCH
![Page 35: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/35.jpg)
Michigan
Death Certificates with Any Mention of Enterocolitis caused by C. difficile
020406080
100120
1999 2000 2001 2002 2003 2004 2005
No
. of
case
s
<40
40-49
50-59
60-69
70-79
80-89
90 and up
Source: 2005 death file, data records and health data development section MDCH
![Page 36: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/36.jpg)
• Boston, 1998¹– Low attributable mortality– Average 3,600 excess cost per case– Average of 3.6 extra hospital days
• Pittsburgh, 20002
– Life-threatening disease from 1.6% to 3.2%– 2000-2001: 26 colectomies and 18 deaths
• Quebec, 2004– 30-day attributable mortality 6.9%– 12-month attributable mortality 16.7%– Average of 10.7 extra hospital days
Increasing Severity and Costs of CDAD
1. Dallal RM, et al. Ann Surg. 2002;235:363-372.2. Muto C, et al. Infect Control HospEpid. 20053. Pepin J, et al. CMAJ. 2005
![Page 37: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/37.jpg)
Changing epidemiology
• Old model of disease; the patient carried the organism into the hospital with them, antibiotics during hospitalization induce toxin production and disease– This hypothesis was tested by culture of
hospitalized patients on admission and then weekly
– The model proved false
![Page 38: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/38.jpg)
Changing epidemiology• New model for C. difficile disease; the organism is not
usually endogenous, antibiotics during hospitalization predispose the patient to colonization, the organism is then acquired in the hospital and causes disease; a nosocomial infection
• In fact, one study showed that colonization with C. difficile prior to hospitalization was protective against C. difficile disease after hospitalization
• Neonates often carry the organism but lack the receptors for the toxin, do not get disease
![Page 39: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/39.jpg)
Epidemiology
• Asymptomatic colonization– Community surveys show that 1-3% of the population
normally carries the organism asymptomatically– Among hospitalized patients, 20% carry it
• CDAD was associated with elderly and long LOS inpatients and nursing homes– Now increasing in non-patients as a community-
acquired disease, in children and young adults, with little antibiotic pre-exposure
• CDAD was associated with use of clindamycin and cephalosporins
![Page 40: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/40.jpg)
Epidemiology; inciting agents and risk factors
• Almost all antibiotics and many antineoplastic agents have caused disease– Most commonly cited: beta-lactams,
clindamycin, fluoroquinolones– Less commonly cited; Timentin,
tetracyclines, SXT, aminoglycosides
• Risk factors:– Advanced age, underlying illness,
immunologic susceptibility (IgG, not cellular)
![Page 41: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/41.jpg)
Recent studies
• Pepin, et al. 2005. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea; a cohort study during an epidemic in Quebec (CID 41:1254-1260)– Since 2002, 30 hospitals, 7000 cases, rate of
15/10,000 patient days, increase in severe disease– Quinolone use had an odds ratio of 3.44, 2nd
generation cephalosporins 1.89– The drug made a difference; gatifloxacin was worst,
levofloxacin was best
![Page 42: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/42.jpg)
Recent studies
• Loo, et al. 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. NEJM 353:2442-2449.– Studied 12 Quebec hospitals, 1719 patients, 22.5/1000
admissions– Attributable mortality was 6.9%– Of 157 isolates from 9 hospitals, 129 were identical– All isolates were susceptible to metronidazole and
vancomycin– Aminoglycosides and penicillins were protective (odds
ratio), cephalosporins, fluoroquinolones and clindamycin were associated with disease
![Page 43: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/43.jpg)
Recent studies
• McDonald, et al. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. NEJM 353:2433-2442– Collected 187 strains from 8 hospitals in Georgia,
Illinois, Maine, New Jersey, Oregon and Pennsylvania in 2003
– Typed by restriction endonuclease typing, PFGE, toxin typing
– Compared with a library of older C. difficile strains– Most of the new strains were identical, and were
different from all strains collected before 2001– The new toxin genes and fluoroquinolone resistance
are new
![Page 44: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/44.jpg)
Infection Prevention Mitigation
![Page 45: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/45.jpg)
Prevention Strategies: Core
• Contact Precautions for duration of diarrhea• Hand hygiene in compliance with CDC/WHO• Cleaning and disinfection of equipment and
environment• Laboratory-based alert system for immediate
notification of positive test results• Educate about CDI: HCP, housekeeping,
administration, patients, families
http://www.cdc.gov/ncidod/dhqp/id_CdiffFAQ_HCP.htmlDubberke et al. Infect Control Hosp Epidemiol 2008;29:S81-92.
![Page 46: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/46.jpg)
Prevention Strategies: Supplemental
• Extend use of Contact Precautions beyond duration of diarrhea (e.g., 48 hours)*
• Presumptive isolation for symptomatic patients pending confirmation of CDI
• Evaluate and optimize testing for CDI• Implement soap and water for hand hygiene before
exiting room of a patient with CDI• Implement universal glove use on units with high CDI
rates*• Use sodium hypochlorite (bleach) – containing agents
for environmental cleaning• Implement an antimicrobial stewardship program
* Not included in CDC/HICPAC 2007 Guideline for Isolation Precautions
![Page 47: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/47.jpg)
Supplemental Prevention Strategies: Consider presumptive isolation for patients
with > 3 unformed stools within 24 hours• Patients with CDI may contaminate environment and
hands of healthcare personnel pending results of diagnostic testing
• CDI responsible for only ~30-40% of hospital-onset diarrhea
• However, CDI more likely among patients with >3 unformed (i.e. taking the shape of a container) stools within 24 hours– Send specimen for testing and presumptively isolate patient
pending results– Positive predictive value of testing will also be optimized if
focused on patients with >3 unformed stools within 24 hours– Exception: patient with possible recurrent CDI (isolate and test
following first unformed stool)
![Page 48: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/48.jpg)
Supplemental Prevention Strategies:
Glove Use Rationale for considering universal glove use
(in addition to Contact Precautions for patients with known CDI) on units with high CDI rates
• Although the magnitude of their contribution is uncertain, asymptomatic carriers have a role in transmission
• Practical screening tests are not available • There may be a role for universal glove use as a
special approach to reducing transmission on units with longer lengths of stay and high endemic CDI rates
• Focus enhanced environmental cleaning strategies and avoid shared medical equipment on such units as well
![Page 49: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/49.jpg)
Supplemental Prevention Strategies:
Environmental Cleaning• Bleach can kill spores, whereas other standard disinfectants cannot
• Limited data suggest cleaning with bleach (1:10 dilution prepared fresh daily) reduces C. difficile transmission
• Two before-after intervention studies demonstrated benefit of bleach cleaning in units with high endemic CDI rates
• Therefore, bleach may be most effective in reducing burden where CDI is highly endemic
Mayfield et al. Clin Infect Dis 2000;31:995-1000.
Wilcox et al. J Hosp Infect 2003;54:109-14.
![Page 50: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/50.jpg)
Supplemental Prevention Strategies:
Environmental CleaningAssess adequacy of cleaning before changing
to new cleaning product such as bleach• Ensure that environmental cleaning is adequate and
high-touch surfaces are not being overlooked• One study using a fluorescent environmental marker to
asses cleaning showed:– only 47% of high-touch surfaces in 3 hospitals were cleaned – sustained improvement in cleaning of all objects, especially in
previously poorly cleaned objects, following educational interventions with the environmental services staff
• The use of environmental markers is a promising method to improve cleaning in hospitals.
Carling et al. Clin Infect Dis 2006;42:385-8.
![Page 51: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/51.jpg)
Summary of Prevention Measures
• Contact Precautions for duration of illness
• Hand hygiene in compliance with CDC/WHO
• Cleaning and disinfection of equipment and environment
• Laboratory-based alert system
• CDI surveillance• Education
• Prolonged duration of Contact Precautions*
• Presumptive isolation • Evaluate and optimize
testing• Soap and water for HH
upon exiting CDI room• Universal glove use on
units with high CDI rates*• Bleach for environmental
disinfection• Antimicrobial stewardship
program
Core Measures Supplemental Measures
* Not included in CDC/HICPAC 2007 Guideline for Isolation Precautions
![Page 52: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/52.jpg)
Measurement: Process Measures
• Core Measures:– Measure compliance with CDC/WHO
recommendations for hand hygiene and Contact Precautions
– Assess adherence to protocols and adequacy of environmental cleaning
• Supplemental Measures:– Intensify assessment of compliance with process
measures– Track use of antibiotics associated with CDI in a
facility
![Page 53: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/53.jpg)
HAND HYGIENE MONITORING TOOLPatient Care Unit/Dept.:___________________________ Day of Week: ________ Date: Initials of Monitor: Time: ________AM/PM to __AM/PM Healthcare Worker (HCW) Type: Key: 1 = Physician 8 = Physical Medicine Staff HW = Hand Wash2A = House Officer 9 = Environmental Services Worker HA = Alcohol Hand Antiseptic2B= Medical Student 10 = Patient Transporter Y = Yes2C= PA 11 = Radiology Tech. N= No3 = Physician Support Staff 12 = Respiratory Therapist N/A = Not Applicable 4 = Nursing/Nursing Support 13 = Dietitian D = Bed closest to door5 = Continuing Care/Social Worker 14 = Traypasser W = Bed closest to window 6 = Pastoral Care 15 = Other
7 = IV Team
BED LOCATION () D W
D W
D W
D W
D W
D W
D W
D W
D W
D W
CONTACT PRECAUTIONS: Y, N, N/A
HEALTH CARE WORKER TYPE ()
OPPORTUNITY REQUIRING HANDHYGIENE INTERVENTION
Before Patient Contact
After Contact With Patient’s Skin
After Contact With Patient’s Gown/Linen
![Page 54: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/54.jpg)
Strategies for LTC
![Page 55: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/55.jpg)
2007 Isolation Precautions *
• Multidisciplinary HICPAC group
• Standard Precautions• Transmission-based
Precautions• Respiratory Hygiene
added• Safe injection practices
added• Term “nosocomial”
replaced by “healthcare-associated” infection
* http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Isolation2007.pdf
![Page 56: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/56.jpg)
2007 HICPAC Isolation Precautions*
• Administrative measures• MDRO education• Judicious use of antimicrobials• Surveillance• Infection Precautions• Environmental measures
*http://www.cdc.gov/ncidod/dhqp/gl_isolation.html
![Page 57: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/57.jpg)
Standard Precautions• Previously called Universal Precautions
• Assumes blood and body fluid of ANY patient could be infectious
• Recommends PPE and other infection control practices to prevent transmission in any healthcare setting
• Decisions about PPE use determined by type of clinical interaction with patient
• Standard precautions INCLUDES Hand Hygiene
![Page 58: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/58.jpg)
PPE for Standard Precautions (1)
• Gloves – Use when touching blood, body fluids, secretions, excretions, contaminated items; for touching mucus membranes and nonintact skin (remove before leaving the area)
• Gowns – Use during procedures and patient care activities when contact of clothing/ exposed skin with blood/body fluids, secretions, or excretions is anticipated
![Page 59: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/59.jpg)
PPE for Standard Precautions (2)
• Mask and goggles or a face shield – Use during patient care activities likely to generate splashes or sprays of blood, body fluids, secretions, or excretions
![Page 60: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/60.jpg)
PPE for Expanded Precautions
Expanded Precautions include Contact Precautions
Droplet Precautions
Airborne Infection Isolation
![Page 61: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/61.jpg)
Modes of Transmission of Infectious Diseases:
– Contact: • Direct = germ transferred directly from patient to
caregiver; e.g. scabies • Indirect = transfer of germs via intermediate object or
person; e.g. caregiver picks up germs from contaminated surface and transfers to the patient
– Droplet: germ in droplets (> 5µ) produced from person with infection when they cough or sneeze; droplets only travel 3 feet; example: influenza
– Airborne: germ in droplet nuclei (< 5µ) that become airborne and can travel long distance and be inhaled deep into lung; example: TB
– Additional Modes: Common source vehicle = e.g. contaminated food item; Vectorborne = transmitted by insect; example: West Nile virus
![Page 62: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/62.jpg)
Use of PPE for Expanded Precautions
Contact Precautions – Gown and gloves for contact with patient or environment of care (e.g., medical equipment, environmental surfaces)
In some instances these are required for entering patient’s environment
Droplet Precautions – Surgical masks within 3 feet of patient
Airborne Infection Isolation – Particulate respirator*
*Negative pressure isolation room also required
![Page 63: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/63.jpg)
Visitors please check with nursesbefore entering room
STOPSTOPSTOPSTOP
Healthcare workers must do the following:
Gloves and gowns required for all direct patient contacts Mask required for direct resident contact Door may remain open Other instructions _______________
When leaving room: Remove all PPE (personal protective equipment)
Perform hand hygieneAlways follow Standard Precautions PLUS
Questions? Contact ___________________ ext.______
S A M P L E
![Page 64: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/64.jpg)
Hand Hygiene
• Required for Standard and Expanded Precautions
• Perform…
Immediately after removing PPE
Between patient contacts
• Wash hands thoroughly with soap and water or use alcohol-based hand rub
![Page 65: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/65.jpg)
Opportunities for
Hand Hygiene
![Page 66: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/66.jpg)
Infection Control Precautions
• Hand Hygiene• Hand washing continued…
– Before and after contact with food, products for food preparation and before eating
– Following any contact with pets during animal assisted therapy or visitation and after contact with any pet care item
• Hand sanitizer– Before any direct patient contact
– After contact with resident’s skin
– After contact with body fluids, mucous membranes, and non-intact skin or dressing, provided hands are not visibly soiled
– After contact with inanimate objects in the care environment
![Page 67: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/67.jpg)
Infection Control Precautions
• Hand Hygiene• Discourage use of artificial nails• Educate patient family and volunteers• Observe compliance
![Page 68: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/68.jpg)
Infection Control Precautions
• Hand Hygiene– Written policy– Hand washing facilities, alcohol-based hand
sanitizer available– When to use each
• Hand washing– Anytime hands are visibly soiled– After toileting
![Page 69: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/69.jpg)
Poor Adherence
• Time• Access• Understanding
![Page 70: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/70.jpg)
CDC:HICPAC Management of Multi-drug-Resistant Organisms
• Routine measures• Enhanced measures
•Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006
![Page 71: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/71.jpg)
MDRO Control Measures• Administrative support • Education • Judicious use of antimicrobial agents • MDRO surveillance
– Surveillance for MDROs isolated from routine clinical cultures • Antibiograms • MDRO Incidence Based on Clinical Culture Results • MDRO Infection Rates • Molecular typing of MDRO isolates
– Surveillance for MDROs by Detecting Asymptomatic Colonization • Infection Control Precautions
– Standard Precautions – Contact Precautions – Cohorting and other MDRO control strategies – Duration of Contact Precautions – Barriers used for contact with patients infected or colonized with MDROs – Impact of Contact Precautions on patient care and well-being
• Environmental measures • Decolonization
![Page 72: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/72.jpg)
MDRO Infection Precautions
• Prioritize patient placement to single bed room and use of isolation, Expanded Precautions with given criteria, discontinue isolation when criteria met
• Observe compliance to Standard Precautions, report back to HCW
• Observe compliance to Hand Hygiene, visibly soiled, before and after patient contact, before performance of aseptic procedure, and after removing gloves
![Page 73: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/73.jpg)
MDRO Environmental Measures
• Practices for cleaning /disinfecting are standardized for all areas -routine, isolation
• Standardized training– monitoring compliance• Environmental cleaning should focus on frequently
touched surfaces with contaminated hands• Sequence of cleaning: cleanest areas to dirtiest• Minimize dust accumulation• Use appropriate agent- following mftr rec.
– Amount– Dilution– CONTACT TIME
![Page 74: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/74.jpg)
The Inanimate Environment Can Facilitate Transmission
~ 16/151 (10.6%) surfaces sampled where transfer via hands of HCW was documented ~
Duckro AN, et al. Arch Intern Med 2005;165:302-7
X represents VRE culture positive sites
![Page 75: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/75.jpg)
Attention to the Environment• Frequently touched surfaces• Areas contaminated with feces• In an outbreak setting or in highly endemic units
use diluted 5.25-6.15% sodium hypochlorite diluted 1:10 for routine disinfection*
• EPA registered hypochlorite based disinfectant• Cleaning
– Pre-cleaning– Order of cleaning– Dilution, contact time
*Rutala, WA, 2005 http://disinfectionandsterilzation.org
![Page 76: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/76.jpg)
Environmental Measures Con’t
• Laundry Avoid contact with body, clothing– No shaking/aerosolizing bedding Contain soiled laundry in a bin/bag segregate soiled from clean
• Patient care equipment– Cleaned according to mftr rec– Between patients– Dedicated to isolation rooms– Return to stock protocols
![Page 77: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/77.jpg)
Facility
• Verify facility is using bleach – NOT quaternary ammonia
• Increase frequency of housekeeping• Stress importance of all items to disinfect• Observe housekeeping
– Fresh solution– Proper bleach concentration– Order of disinfection
![Page 78: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/78.jpg)
Items to Disinfect• Faucets, toilet seats, sinks, light switches,
counter tops• Doorknobs, hand rails, elevator buttons,
washroom door plates• ANY commonly used item that multiple people
may come in contact with• Order of disinfection matters!
– “Start out and work in”
![Page 79: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/79.jpg)
Surveillance
• Methods- Standardized, Definitions, Denominators– Whole-house limitations– Targeted, point prevalence– Device related– Combination– Based on high risk, high volume problem
areas
![Page 80: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/80.jpg)
Surveillance
• Purpose– Improve quality and outcome of healthcare– Promote public health– Benchmarking
• NHSN- www.cdc.gov/ncidod/hip– NNIS– NaSH– DSN
![Page 81: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/81.jpg)
Surveillance
• Data Collection– What
• System • Process• Outcome
– Identify sources• Lab reports• Unit reports• Pharmacy• observational
![Page 82: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/82.jpg)
Surveillance
• Analysis• Reports
– Infection Control Committee– Quality Committee– Administrator – Medical Director– Director of Nursing– Unit– Front line personnel– Physicians
![Page 83: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/83.jpg)
Surveillance
• Intervention of risk-reduction measure– Documented
• Evaluate effectiveness of intervention
• See Websites– http://www.cdc.gov/ncidod/hip/
http://www.cdc.gov/ncidod/hip/Guide/guide.htm
![Page 84: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/84.jpg)
Patient Care Protocols
• Standardized processes for wound care– Aseptic/clean technique– covered
• Standardized processes for catheter care• Teach the patient/family members about
good hand hygiene– Especially after incontinence care for both care
provider and patient– Before they eat
![Page 85: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/85.jpg)
Control of C. difficile
• In the healthcare facility:– Prompt diagnosis– Isolation precautions,
hand hygiene– Stop unneeded
antibiotics – Good environmental
cleaning• In the community:
– Avoid unnecessary antibiotic use
![Page 86: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/86.jpg)
Future answers?
• Improve infection control • Avoid unnecessary antibiotics• Probiotics to restore the normal microbial
balance• Vaccine to produce protective antibody• Immune globulin for passive immunity• Non-antibiotic therapies like resins
![Page 87: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/87.jpg)
Summary for Prevention in Healthcare
• Isolate patients with C. difficile in a private room, or cohorted• Attention to Hand Hygiene
– Soap and water– ABHR
• PPE• Dedicate equipment• Isolate as long as diarrhea is present• Individualized patient assessment is required• Conduct surveillance for CDI• Judicious use of antibiotics (clindamycin)• Early detection, isolation and treatment
![Page 88: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/88.jpg)
Resources
• http://www.cdc.gov/HAI/pdfs/toolkits/CDItoolkitwhite_clearance_edits.pdf
• www.apic.org
• http://www.cdc.gov/hicpac/pubs.html
• www.who.int/patientsafety/en
• http://www.mi-marr.org/ (Long-Term Care Toolkit)
![Page 89: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/89.jpg)
http://www.cdc.gov/HAI/organisms/cdiff/Cdiff_infect.html
• Frequently asked questions document for healthcare providers
![Page 90: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/90.jpg)
Additional resources
Dubberke et al. Infect Control Hosp Epidemiol 2008;29:S81-92.Abbett SK et al. Infect Control Hosp Epidemiol 2009;30:1062-9.
SHEA/IDSA Compendium of Recommendations CDI Checklist Example
![Page 91: Clostridium Management in Long-Term Care](https://reader035.fdocuments.in/reader035/viewer/2022062723/56813b55550346895da446b4/html5/thumbnails/91.jpg)
Acknowledgements
• Dr. Richard Van Enk
• Dr Clifford McDonald